Bank of America’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-297
Closed -$544 6897
2025
Q4
$544 Buy
297
+287
+2,870% +$660 ﹤0.01% 6548
2025
Q3
$25 Buy
10
+4
+67% +$13 ﹤0.01% 8140
2025
Q2
$26 Buy
6
+2
+50% +$11 ﹤0.01% 8212
2025
Q1
$23 Buy
4
+1
+33% +$8 ﹤0.01% 8112
2024
Q4
$29 Buy
+3
New +$26 ﹤0.01% 7965
2024
Q3
Hold
0
8107
2024
Q2
Hold
0
7907
2023
Q3
Hold
0
-$85 7969
2023
Q2
Hold
0
7435
2022
Q1
Hold
0
8800
2021
Q4
Sell
-2
Closed -$47.7K 8672
2021
Q3
$50K Hold
2
﹤0.01% 7044
2021
Q2
$70K Buy
2
+1
+100% +$41.6K ﹤0.01% 6691
2021
Q1
$41K Buy
+1
New +$65.4K ﹤0.01% 6703

Other funds holding VTAK

Bank of America's VTAK Position: Q1 2026 in Review

Bank of America sold out of Catheter Precision (VTAK) in Q1 2026, closing a stake of 297 shares — an estimated $544 sold.

Bank of America first reported a position in VTAK in Q1 2021 and held it in 8 quarters. The position peaked at $70K in Q2 2021. 12 funds tracked by Wall St. Rank hold VTAK as of Q1 2026.

  • Bank of America reported no remaining Catheter Precision position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 297 Catheter Precision shares in Q1 2026, an estimated $544.
  • Bank of America first reported a position in Catheter Precision in Q1 2021 and held it in 8 quarters.
  • Bank of America's Catheter Precision position peaked at $70K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.